Funding for this research was provided by:
the Horizontal Subject “effect of biomimetic mineralized collagen artificial bone in the treatment of spinal diseases and fractures” of Dongzhimen Hospital Beijing University of Chinese Medicine (HX-DZM-2018010)
Received: 31 October 2022
Accepted: 5 January 2023
First Online: 12 January 2023
: We declare that the study has been performed in accordance with the Declaration of Helsinki and has been approved by the institutional review board of Dongzhimen Hospital Beijing University of Chinese Medicine (approval number: 2022DZMEC-085-04). All patients participated free-willingly and with written informed consent to the study.
: Not applicable.
: The authors declare that there are no conflicts of interest regarding the publication of this paper.